June 2026
The global exosome therapeutics market size is evaluated at USD 928.93 thousand in 2025 and is predicted to hit around USD 4,564.32 thousand by 2035, with a CAGR of 17.26%.
September 2026
The Europe urinary incontinence therapeutics market was valued at USD 11.77 billion in 2025 and is expected to expand at a CAGR of 3.15% from 2026 to 2035. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The anti-inflammatory therapeutics market size was estimated at USD 113.58 billion in 2026 and is expected to hit USD 164.44 billion by 2035, with a CAGR of 4.14%.
September 2026
The global dermatology diagnostic devices and therapeutics market size is projected to hit around USD 31.33 billion by 2035 from USD 17.03 billion in 2026, with a CAGR of 7.02%.
September 2026
The U.S. digital therapeutics market size is exhibited at USD 4.56 billion in 2026 and is predicted to surpass USD 24.09 billion by 2035 with a remarkable CAGR of 20.54%.
September 2026
The global amyloidosis therapeutics market size was valued at USD 3.44 billion in 2026 and is expected to hit around 6.92 billion by 2035, growing at a CAGR of 8.09% from 2026 to 2035.
September 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.49 billion in 2026 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
September 2026
The mRNA vaccines and therapeutics market size reached USD 130.20Â billion in 2026 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
September 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.51 billion in 2026 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The microbiome therapeutics market size reached USD 334.16 million in 2026, with leading microbiome therapeutics market companies including Seres Therapeutics, Nestlé Health Science, Finch Therapeutics.
September 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
September 2026
The homecare diagnostics & therapeutics market size accounted for USD 291.51 billion in 2026 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
September 2026
The global cancer therapeutics market size was evaluated at USD 232.14 billion in 2026 and is expected to surpass around USD 501.07 billion by 2035 with a CAGR of 8.95%.
September 2026
The pruritus therapeutics market size stood at USD 12.26 billion in 2026, with major pruritus therapeutics market companies including Bristol-Myers Squibb, Novartis AGÂ , Pfizer Inc.,Teva Pharmaceuticals.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The mRNA therapeutics market size was valued at USD 22.30 billion in 2026 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
September 2026
The global scleroderma therapeutics market size is projected to surpass around USD 4.48 billion by 2035 increasing from USD 2.88 billion in 2026, with a CAGR of 5.04%.
September 2026
The global small interfering RNA (siRNA) therapeutics market size is estimated to hit around USD 528.78 billion by 2035 increasing from USD 214.41 billion in 2026, with a CAGR of 10.55%.
September 2026
The global melanoma therapeutics market size accounted for USD 8.16 billion in 2026 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
September 2026
The global targeted therapeutics market size was estimated at USD 91.76 billion in 2026 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
September 2026
The global non-Hodgkin's lymphoma therapeutics market size is estimated to hit around USD 20.94 billion by 2034, increasing from USD 11.80 billion in 2026, with a CAGR of 7.43%.
September 2026
The global narcolepsy therapeutics market size is accounted at USD 4.46 billion in 2026 and is expected to hit around USD 9.31 billion by 2035 with a CAGR of 8.49%.
September 2026
The global women's health therapeutics market size is predicted to hit around USD 66.62 billion by 2034 from USD 48.57 billion in 2026, with a CAGR of 4.03%.
September 2026
The exosome drug delivery services market size was USD 5.70 billion in 2026, with leading exosome drug delivery services market players including CD Bioarticles, Danaher, Fujifilm, Illumina.
September 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 2.14 billion in 2026 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
September 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
September 2026
The global plasma protein therapeutics market size is projected to cross around USD 48.43 billion by 2034 from USD 32.66 billion in 2026 with a CAGR of 5.06%.
September 2026
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com